CHD9-DLC1 Fusion FISH Probe
The CHD9-DLC1 Fusion FISH Probe is used to confirm a fusion of the CHD9 and DLC1 genes. The fusion of the CHD9 and DLC1 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| CHD9-DLC1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| CHD9-DLC1-20-AQAQ | 20 (40 μL) | 200 μL |
|
DLC1 Gene Summary
This gene encodes a GTPase-activating protein (GAP) that is a member of the rhoGAP family of proteins which play a role in the regulation of small GTP-binding proteins. GAP family proteins participate in signaling pathways that regulate cell processes involved in cytoskeletal changes. This gene functions as a tumor suppressor gene in a number of common cancers, including prostate, lung, colorectal, and breast cancers. Multiple transcript variants due to alternative promoters and alternative splicing have been found for this gene.[provided by RefSeq, Apr 2010]
Gene Name: DLC1 Rho GTPase Activating Protein
Chromosome: CHR8: 12940871 -13372429
Locus: 8p22
CHD9 Gene Summary
The Chromodomain Helicase DNA Binding Protein 9 (CHD9) gene is located on chr16 :53088944-53361414 at 16q12.2.
Gene Name: Chromodomain Helicase DNA Binding Protein 9
Chromosome: CHR16: 53088944 -53361414
Locus: 16q12.2
Gene Diseases
The CHD9 DLC1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|